Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Regulatory Filings 2021

Nov 18, 2021

50715_rns_2021-11-18_e7d86f5f-3c50-4870-92dc-33c3eb6c4a14.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities.

These materials contained in this announcement are not for distribution, publication or circulation, directly or indirectly, in or into the United States.

This announcement is solely for the purpose of reference and does not constitute an offer of securities for sale or an invitation to purchase securities in the United States or any other jurisdiction. The securities described herein have not been and will not be registered under the U.S. Securities Act of 1933 (the ‘‘U.S. Securities Act’’) or under any securities laws of any state or other jurisdiction of the United States. Unless exempt from registration and in compliance with the securities laws of any state or other jurisdiction of the United States, the securities described herein may not be sold, offered for sale, resold, transferred or delivered, directly or indirectly, within the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act). There will be no public offer or sale of the securities described herein in the United States or to, or for the benefit of, any U.S. persons or in any other jurisdiction.

NOTICE OF LISTING ON THE STOCK EXCHANGE OF HONG KONG LIMITED

YANCOAL INTERNATIONAL RESOURCES DEVELOPMENT CO., LIMITED

(incorporated with limited liability in Hong Kong)

U.S.$300,000,000 2.90% Senior Guaranteed Bonds due 2024 (the ‘‘Bonds’’)

(Stock Code: 40928)

unconditionally and irrevocably guaranteed by

Yanzhou Coal Mining Company Limited

(a joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1171)

Joint Global Coordinators, Joint Lead Managers and Joint Bookrunners

Deutsche Bank CMB International Haitong International

Joint Lead Managers and Joint Bookrunners

Deutsche Bank CMB International Haitong Industrial Bank China International International Co., Ltd. Capital Corporation Hong Kong Branch

– 1 –

Application has been made to The Stock Exchange of Hong Kong Limited for the listing of, and permission to deal in the Bonds by way of debt issues to professional investors (as defined in Chapter 37 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited) only as described in the offering memorandum dated 15 November 2021. The listing and permission to deal in the Bonds is expected to become effective on 19 November 2021.

Hong Kong, 18 November 2021

As at the date of this announcement, the directors of Yancoal International Resources Development Co., Limited are Mr. Liu Jian, Mr. Wu Xiangqian and Mr. Zhao Qingchun.

As at the date of this announcement, the Directors of Yanzhou Coal Mining Company Limited are Mr. Li Wei, Mr. Liu Jian, Mr. Xiao Yaomeng, Mr. Zhu Qingrui, Mr. Zhao Qingchun, Mr. Wang Ruolin and Mr. Huang Xiaolong, and the independent non-executive Directors of Yanzhou Coal Mining Company Limited are Mr. Tian Hui, Mr. Zhu Limin, Mr. Cai Chang, and Mr. Poon Chiu Kwok.

– 2 –